Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05678530 · ClinicalTrials.gov registry record
Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
A clinical trial of Cardiopulmonary, sponsored by Prolaio.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 16
- Study locations
NCT05678530 is a study of Cardiopulmonary that is actively recruiting participants, run by Prolaio. The registered enrollment target is 1,000 participants. The trial reports 16 study locations across 9 states.
The verdict
NCT05678530, a study of Cardiopulmonary, is actively recruiting participants, sponsored by Prolaio.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
In this study, the hypothesis being explored is that VO2Max and other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using wearable biosensors worn by study participants. This study will aim to collect development and validation data for a machine learning algorithm and to evaluate the performance of the algorithm. A total of 1000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 900 participants.
Conditions Studied
Study Locations (16)
California
- VA Palo Alto Healthcare System - Palo Alto
- University of California San Francisco - San Francisco
- The Lundquist Institute - Torrance
Florida
- Memorial Healthcare System, Office of Human Research - Hollywood
- Mayo Clinic Florida - Jacksonville
- New Generation of Medical Research - Naples
Illinois
- physIQ - Chicago
- University of Illinois Hospital & Health Sciences System - Chicago
- Advocate Aurora Health Institute - Oakbrook Terrace
Texas
- Baylor Scott & White Research Institute - Dallas
- Baylor Scott & White The Heart Hospital - Plano - Plano
Arizona
- Mayo Clinic Arizona - Scottsdale
Delaware
- Nemours Cardiac Center - Wilmington
Minnesota
- Mayo Clinic - Rochester
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05678530
The ClinicalTrials.gov registry entry for NCT05678530 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prolaio, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiopulmonary appearing as the primary indexed condition, and to 0 interventions.
NCT05678530 reports 16 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05678530 about?
NCT05678530 is a clinical study titled "Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)". In this study, the hypothesis being explored is that VO2Max and other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using wearable biosensors worn by study participan...
What is the current status of trial NCT05678530?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-06-06. Estimated completion is 2027-03-31.
What conditions does trial NCT05678530 study?
This clinical trial studies the following conditions: Cardiopulmonary.
Who is sponsoring clinical trial NCT05678530?
This trial is sponsored by Prolaio, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05678530 being conducted?
This trial has 16 study locations across Arizona, California, Delaware, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.